Skip to main content

US ClosedU.S. Closed

BLTE: Belite Bio, Inc Stock Analysis | finqOS

Healthcare · Biotechnology

Belite Bio, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and advancement of novel therapies.

52W Range

65thpctl

Volume

0.90×avg

Market Cap

6.08BUSD

P/E Ratio

-55.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Belite Bio, Inc

BLTENASDAQ Capital Market·USD·Closed

Belite Bio, Inc

BLTENASDAQ·USD·Closed

$151.72

−3.37%

$151.72

−$5.29 (3.37%)

52W Range

65thpctl

Volume

0.90×avg

Mkt Cap

6.08BUSD

P/E

-55.0TTM

Div Yield

–ann